Demcizumab Biosimilar - Research Grade

Human

DLL4ï؟½

5mg/ml

IgG2 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q9NR61

Blue ice

Delta-like ligand 4 (DLL4) is a Notch-pathway ligand that regulates angiogenesis and vascular sprouting, a focus of developmental and tumor-vasculature research. Offered as an unconjugated, non-therapeutic analog of demcizumab, this human IgG2-kappa recombinant antibody is intended for research use only (RUO). It is provided in a low-endotoxin, in vivo-suitable format and manufactured in scalable milligram-to-gram quantities for high-throughput laboratories. The antibody supports functional and ligand-blockade assays, Notch-signaling and angiogenesis studies, in vitro screening and preclinical tumor models examining DLL4 activity. Its low-endotoxin, in vivo-grade formulation and scalable milligram-to-gram supply make it dependable for repeat, high-volume experimentation.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks